AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,520,000 | -12.4% | 78,895 | -24.8% | 3.06% | -26.5% |
| Q2 2022 | $4,017,000 | -9.4% | 104,889 | -2.1% | 4.16% | +29.1% |
| Q1 2022 | $4,436,000 | +2.5% | 107,187 | -6.4% | 3.23% | +21.5% |
| Q4 2021 | $4,327,000 | +15.7% | 114,525 | +1.0% | 2.66% | +7.7% |
| Q3 2021 | $3,739,000 | -18.3% | 113,430 | +67.2% | 2.47% | -18.0% |
| Q2 2021 | $4,576,000 | +53.5% | 67,835 | +28.8% | 3.01% | +43.9% |
| Q1 2021 | $2,981,000 | -17.7% | 52,658 | +18.4% | 2.09% | -27.6% |
| Q4 2020 | $3,623,000 | +30.3% | 44,468 | +14.0% | 2.88% | +4.0% |
| Q3 2020 | $2,780,000 | -14.1% | 39,018 | -0.8% | 2.77% | -21.0% |
| Q2 2020 | $3,236,000 | +29.7% | 39,328 | -7.2% | 3.51% | +8.3% |
| Q1 2020 | $2,495,000 | +339.3% | 42,402 | +670.9% | 3.24% | +482.4% |
| Q4 2019 | $568,000 | – | 5,500 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |